咨询专家

我叫Alec De Grand，是奥林巴斯虚拟载玻片扫描仪和正置显微镜的产品经理。我在奥林巴斯就职超过10多年，曾负责管理过临床产品、营销计划、显微成像课程和贸易展会。

大家好。我是Blent Peker，是您的专职激光扫描显微镜专家。我最初在攻读物理化学博士学位期间对显微镜和光子学产生兴趣，并致力于时间分辨率双光子显微镜的研究。从那时起，我就一直对此充满热情。

我在奥林巴斯工作已超过13年，始终致力于帮助团队将我们最先进的激光扫描显微镜推向市场。我对多光子系统应用以及激光扫描系统的改造可能性深感兴趣。

您好，我叫Chunsong Yan，我是奥林巴斯澳大利亚和新西兰公司生命科学业务发展经理。我目前负责共聚焦、多光子、光片和全玻片扫描系统。我于2003年加入奥林巴斯并任过各类职务，任职期间始终致力于为我们的客户提供最佳奥林巴斯解决方案。

我叫Daniel Bemmerl，我可以帮助您了解3D高内涵分析和类器官成像相关的信息。我加入奥林巴斯时担任TIRF显微镜和高内涵筛选的应用专家，目前则专注于3D分析软件。

我曾经从事分子和发育干细胞生物学研究，之后很快意识到相对于处理标本，我对研究的技术层面，特别是成像本身更加感兴趣。之所以加入奥林巴斯生命科学部门，是因为我更喜欢实验室之外的工作，成为沟通客户与开发部门的桥梁。我非常乐意回答您有关3D成像的任何问题，并帮助您改善成像工作流程，让您能够专注从事研究工作。

大家好。我是Abbelight的首席技术官（CTO）兼联合创始人Nicolas Bourg博士，是您的专职单分子定位显微镜（SMLM）专家- 这类显微镜也被称为纳米显微镜-其中包括PALM、dSTORM、SPT-PALM和DNA-PAINT等技术。

我是一名经过培训的光电工程师，并在巴黎-萨克雷大学获得生物光子学研究领域的博士学位，致力于通过独特3D纳米技术实现前所未有的高分辨率的研究。我与我的研究团队创建了Abbelight这家初创公司，决定分享我在博士学位期间获得的所有知识，致力于让纳米显微镜功能更加强大，且让任何生物学家无需进行高级培训即可掌握显微镜的全面操作。我的工作任务是回答您有关纳米显微镜的所有问题，欢迎与我联系。

大家好，我叫Flavio Giacobone，负责奥林巴斯欧洲市场的全玻片扫描解决方案。从攻读生物医学工程专业学位开始，成像始终与我息息相关，加入奥林巴斯让我能够亲身体验到很多临床和科研领域的数字化转变。我从奥林巴斯第一台扫描仪dotSlide开始，就在整个玻片成像方面积累了专业知识，见证了自第一款产品以来所取得的巨大进步。

我是Ganesh Kadasoor，过去15年一直参与印度的奥林巴斯高端成像业务。我拥有印度迈索尔大学生命科学学士学位和硕士学位，并获得医学昆虫学的博士学位。我以共聚焦专家身份加入奥林巴斯，负责活细胞成像系统、激光扫描共聚焦、TIRF、转盘共聚焦、超分辨率和多光子显微镜等所有高端成像系统。目前我在班加罗尔的Olympus Medical Systems India Ltd.担任全国经理（应用支持），负责为全国科学家、学者和分销商网络提供培训计划。我还负责组织各种显微镜和成像讲习班、研讨会和网络研讨会，并作为印度讲师/培训员为国家和国际显微镜课程提供支持。

大家好，我叫Heiko Gäthje。我在担任生物学家时开始获得宽视场和共聚焦荧光显微镜以及3D数据图像处理方面的专业知识，当时的研究重点是昆虫的神经元发育和哺乳动物唾液酸结合神经元蛋白质的结构。

我于2004年加入奥林巴斯，自2008年以来一直担任奥林巴斯学院的显微培训师，负责介绍数字学习工具的概念和使用。我还支持并参与EMBL海德堡大学和苏黎世冬季高级显微技术学校举办的显微学培训课程，回答诸多与图像处理和图像分析有关的问题。

大家好，我叫Irina，非常期待能够与您一起讨论光片显微镜。我在巴黎笛卡尔大学获得衰老专业的细胞生物学、生理学和病理学硕士学位。在加入PhaseView担任产品经理之前，我曾在神经科学研究实验室（SPPIN）工作，并为显微成像中心平台优化了透明化流程。

嗨，我叫Junsung Kim，是奥林巴斯韩国公司的共聚焦显微镜产品专家。我拥有高丽大学的生物工程硕士学位。我于2014年加入奥林巴斯，负责为客户提供奥林巴斯共聚焦和多光子显微镜的应用支持。

我是Kathy Lindsley，是奥林巴斯为基于相机成像系统提供支持的应用专家。我拥有爱荷华州立大学生物化学专业的理学学士学位。我于2006年加入奥林巴斯，担任研究成像销售代表，并于2012年加入生命科学应用团队。在加入奥林巴斯之前，我曾在学术研究领域担任过15年的研究助理，在膜片钳、钙成像、组织培养和免疫组织化学方面积累了丰富的经验。

大家好。我是Lauren Alvarenga，在奥林巴斯担任研究成像产品经理，目前负责成像软件以及倒置和超分辨率显微镜。我拥有罗彻斯特理工学院的生物医学摄影通讯专业理学学士学位。
甲状旁腺激素对肾脏磷酸转运蛋白Npt2a的转录后调节。我自2015年起一直在奥林巴斯工作，主要为美国、加拿大和拉丁美洲的FLUOVIEW系列产品提供支持。

大家好。我叫Manoel Veiga，是奥林巴斯软件深度学习实施团队成员。我于2017年加入奥林巴斯，拥有高内涵筛选、图像分析和深度学习领域的专业知识。我还是荧光寿命成像的专家。

在攻读物理化学博士学位期间，我开始对数据分析产生兴趣，在了解到卷积神经网络的强大功能及其所能完成难以置信的图像分析任务之后，更加加深了我对这一领域的兴趣。

嗨，我是Minly Kim，是奥林巴斯韩国公司生物显微镜的产品专家。我于2010年加入奥林巴斯，担任活细胞和荧光成像系统的高端销售和产品专家。另外，我还负责韩国经销商的培训计划。

大家好。我叫Rebecca Bonfig，是奥林巴斯的共聚焦显微镜产品经理。我的研究生论文在路易斯维尔大学生理学与生物物理学系完成，研究方向为甲状旁腺激素对肾磷酸盐转运蛋白Npt2a的转录后调控。我自2015年起一直在奥林巴斯工作，主要为美国、加拿大和拉丁美洲的FLUOVIEW系列产品提供支持。

我叫Imamura Shohei，是奥林巴斯的战略项目经理。我在科学显微镜的销售方面拥有4年经验，并在侧重软件的产品规划方面拥有7年经验。我还负责战略项目管理和执行。我拥有日本明治大学的商业学士学位。

大家好！我叫Srivats Hariharan aka Hari，是新加坡奥林巴斯的共聚焦、多光子和超分辨率显微镜产品经理。我拥有新加坡南洋理工大学的机械工程学士学位，并在生物医学研究实验室和A*STAR显微镜核心设施工作，在此期间，我为研究人员提供共聚焦和活细胞成像技术方面的支持，并帮助设置单分子超分辨率和光片显微镜。
我于2011年加入奥林巴斯新加坡生命科学团队，担任产品经理，负责支持东南亚和台湾地区的科研客户和业务合作伙伴。

您好，我叫Stefan Marawske，是您的超分辨率显微镜专家。在攻读物理化学领域博士学位期间，我曾制作过用于基于定位超分辨率和粒子跟踪的自搭建显微镜。我特别沉迷于那些能够突破著名的阿贝极限以及能够分辨以前无法观察结构的方法。

我在奥林巴斯工作了超过7年，主要负责TIRF和转盘等高端成像系统。这类系统通常由于能够将许多不同设备组合用于各种应用而具有高度的灵活性，因此，如果您在确定专用配置方面需要任何帮助，欢迎与我们联系。

我叫Takeo Ogama，是奥林巴斯显微镜相机的高级产品和策略规划师兼产品经理。我在相机等各种产品的研发部门拥有八年的工作经验，也在产品规划、营销和管理方面拥有八年的经验。加入奥林巴斯之前，我从日本大阪大学获得中微子物理学的硕士学位。

大家好！我叫Wei Juan Wong，是临床和研究市场产品的产品专家。我拥有物理学学位，并且在生物物理研究实验室以及显微镜中心平台均具备丰富的工作经验。我于2018年加入奥林巴斯新加坡生命科学团队，担任产品专家，为客户提供应用支持并负责东南亚地区代理商的培训计划。

Hello, I’m Klaus Willeke, Product Marketing Manager at Olympus Life Science Division and I’m responsible for our new X Line objectives. During my geology studies, the polarization microscope was an essential tool for determining and researching mineral compositions and structures. I was always fascinated by how colorful the world of minerals appears through a polarization microscope and how much you can discover with the help of light and good optics.

I’ve been working for Olympus for more than 22 years where I was 17 years a sales representative for industrial and life science microcopy in Germany and after that in European Product Marketing in the Scientific Solutions Division of Olympus, responsible for upright clinical and research microscopes and X Line lenses. 

Dr Hrishikesh Pai did his Fellowship in Reproductive Biology from the Royal Women’s Hospital, Melbourne Australia in 1989. He did his Masters in Clinical Embryology and Andrology from the Jones Institute, Eastern Virginia Medical School, USA in 2006. He has won 45 plus awards including the Honorary FRCOG from the Royal College of Obstetricians & Gynecologists, United Kingdom in 2019. Dr Pai has been the Past President of the Indian Society for Assisted Reproduction (ISAR) and is the present Director of Corporate Affairs for International Federation of Fertility Societies (IFFS). Dr Pai is the President Elect of the Federation of Obstetric and Gynecological Societies of India (FOGSI) with a membership strength of 37,000 members. It is the second largest medical body of gynecologists in the world, only second to the ACOG.

Mr. Hiroya Ishihara is an Application Scientist at Olympus. He was studying the epigenetic factors involved in plant regeneration using omics and microscopy in Tokyo University of Science. Confocal and two-photon microscopy were his trusted partner at that time. Therefore, he joined Olympus to make life science more exciting with microscopes. Currently, he is working on a wide range of projects from basic research to product/sales strategy.

Dr. Gowri Balachander is a Research Fellow at the Yong Loo Lin School of Medicine, National University of Singapore. She completed her PhD at the prestigious Indian Institute of Science, Bangalore, India where she worked on engineering 3D organotypic models for the study of breast cancer metastasis. At NUS, she currently works on morphogenetic models for human liver development and regeneration.

Joanna Hawryluk is a product manager for Olympus Corporation of the Americas located in Waltham, MA. She has been with Olympus since 2017 within the Marketing department specializing in our 3D cell analysis software, lightsheet microscopy, electrophysiology, and our cell culture monitoring system. Dr. Hawryluk received her doctorate degree in Physiology and Neurobiology in 2016 from the University of Connecticut.

Benjamin received his Ph.D. from the University of Bordeaux. During his Ph.D., in the group of Dr. Choquet at the Interdisciplinary Institute for Neuroscience, he studied the nanoscale organization of glutamate receptors at excitatory synapse and its importance for synaptic plasticity. In 2018, he joined the lab of Professor Burrone at King’s College London for his postdoc where he investigates the molecular organization of inhibitory synapses and its role in regulating neuronal firing, a project for which he obtained a Marie Sklodowska-Curie Action postdoctoral fellowship.

Lin got his PhD back in 2010 in National University of Singapore working on biophysical research. From 2009 he joined Olympus as Technical and Application specialist taking care of laser based high end imaging system. In 2012, Lin decided to move back to China and taking a position with one of the leading scientific camera manufacturers Photometrics. There, he started as application specialist, later become regional sales manager and finally scientific sales manager for Asia Pacific. In 2021, Lin moved back to Singapore, joining Olympus Singapore as the manager for product and application. Lin has a long experience of various techniques on scientific digital imaging including various camera technologies.

Hello, my name is Angela Vasaturo, the senior field application scientist at Ultivue. My passion for micro-biology and live-cell imaging began during my post-doc, where I was involved in the early development of multiplex IHC in Europe.
I built my expertise through extensive involvement in post-doc research focused on tumor immunology at the NCMLS in Nijmegen, NL, as well as during my position as Senior Researcher in Dr. Jerome Galon’s Laboratory of Integrative Cancer Immunology at the Cordeliers Research Center.

My name is Shogo Usui and I'm product leader of CM20 at Olympus Corporation.

For over ten years, I have been an electrical engineer in the life science R&D team in Olympus Tokyo. I hold a Master’s degree in applied physics from the University of Electrical and Communication from Tokyo, Japan.

Dr. Anne Beghin is a multidisciplinary scientist with fifteen years of extensive research experience across academia and industry. She obtained her PhD in oncology in 2007 at the University Claude Bernard in Lyon (France). She then moved to optical microscopy at the Université de Lyon, where she established the microscopy platform and developed live cell imaging solutions and image analysis services for 4 years.

In 2011, she was recruited by a biotechnology company based in Bordeaux, where she spent 3 years in charge of a tissue analysis service: from biologic samples (whole tissue sections and Tissue Micro Arrays) to image acquisition and analysis with database establishment. She has been part of the Interdisciplinary Institute of NeuroScience IINS for 3 years where she successfully developed a new platform linking the High Content Screening (HCS) approach with super resolution microscopy such as Single Molecule Light Microscopy (HCS-SMLM), a collaboration with pharmaceutical company, Sanofi. Subsequently, she moved to the MechanoBiology Institute (MBI) in Singapore to study organoids using advanced imaging and HCS. This work has resulted in a patent and publications are on-going.

Dr. Xiaotong Cui received his B.S. and M.Sc. from the University of Leicester, UK. He went on to receive aPh.D. from the Institute of Life Science, Kyoto University in 2018, where he worked under the direction of Prof. Osamu Takeuchi. From 2018-2020, he was a program-specific researcher in Shenzhen Digital Life Institute and ASHBi, Japan. Dr. Xiaotong has a solid background in molecular cell biology, immunology and he participated in one special program for Key Basic Research of Ministry of Science and Technology, China. Now, he serves as a Field Application Specialist in Bio-Techne China.

Dr. Kasmira Wilson is a general surgeon and CSSANZ trainee, having previously completed a BSc(Hons) and MBBS. She is currently undertaking a PhD through the University of Melbourne at Peter MacCallum cancer centre which focuses on translational research in rectal cancer. Her research utilises tumouroid models to explore anti-tumour immunity in rectal cancer in a novel functional cytotoxic assay.

Dr. Dan Zhu is a professor of Huazhong University of Science & Technology, and Vice-Director of Wuhan National Laboratory for Optoelectronics. Her research interests mainly focus on tissue optical clearing imaging and applications. She is the pioneer in the field of in vivo tissue optical clearing, and also developed fast, label-compatible in vitro optical clearing methods. She has authored more than 150 papers including Science Advances, Nature Communications, et al. She is also Fellow of SPIE, and Secretary General & Vice President of Biomedical Photonics Committee of Chinese Optical Society. She serves for journals as editorial member or guest editor, including Biomedical Optics Express, Journal of Biomedical Optics, Scientific Reports, Journal of Innovative Optical Health Sciences, Frontier of Optoelectronics et al.

Dr. Graham Wright holds an interdisciplinary PhD in cell biology and physics from The University of Edinburgh and an MBA from the Warwick Business School at The University of Warwick. He is the Acting Director of A*STAR’s Research Support Centre (RSC) and the Director of the A*STAR Microscopy Platform (AMP). RSC offers everything from on-demand access to sophisticated scientific instruments and services, located within varied Technology Platforms, to a research consumables webstore, playing a crucial role in powering biomedical innovation in Singapore.

Dr. Graham has extensive experience, and a strong publication record, in applying advanced light microscopy to a wide range of biomedical research projects. Outside the laboratory, he is committed to science outreach and has featured as a judge on MediaCorp’s National Science Challenge TV show, presented a TEDx talk, had microscopy images displayed on the big screen in Times Square, New York and exhibited work at the National Museum of Singapore.

Mr. Srivats Hariharan is an Applications & Marketing Manager in Olympus life science team in the Asia Pacific region. He holds a bachelor’s degree in Mechanical Engineering from Nanyang Technological University, Singapore and has experience working in biomedical research labs and A*STAR Microscopy Core Facility where he supported researchers on confocal and live cell imaging technologies and help setup single molecule super-resolution and light sheet microscopes. He joined the life-science team of Olympus Singapore in 2011 as Product Manager and in-charge of supporting research customers and business partners in South-East Asia and Taiwan.

Ms. Gency Gunasingh completed her Master of biotechnology degree from University of Queensland in 2012 and did her Masters project under Dr. Andrew Prowse and Prof. Peter Gray at Australian Institute for Bioengineering and Nanotechnology. Her primary area of research was large scale generation of cardiac progenitors from embryonic stem cells in 3D. She then worked under Prof. Brian Gabrielli at UQ Diamantina institute on developing 3D tumour spheres in melanoma for in vitro drug testing. She currently works for Prof. Nikolas Haass at UQDI on understanding tumour heterogeneity and tumour architecture in melanoma spheroids.

Dr. Dong Gao is the Principal Investigator of Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. His research interests mainly focus on t prostate adult stem cell and the establishment of patients-derived cancer organoid biobank. He has authored more than 40 papers including Cell, Nature Genetics, Cell Stem Cell et al.

Dr. Yu Weimiao obtained his Ph.D. from the National University of Singapore (NUS) in 2007, majoring in image processing and machine vision. He joined the Agency of Science, Technology and Research (A*STAR) in 2007. He is currently heading Computational Digital Pathology Lab (CMPL) in BII to deepen and extend the R&D with clinical and industrial partners. He is also the joint PI in IMCB leading the Computational & Molecular Pathology Lab (CMPL). His research interests are Computational Biomedical Image Analysis and Quantitative Imaging Informatics. He applied 3D image analysis solution to segment and tracking the cells in 3D to understand the developmental problem and collective cell migration mechanisms. His work was published in Nature Communication, Current biology, Nature Cell Biology, etc. To enhance the applications in clinical diagnosis/prognosis, he co-founded a biotech company, known as A!maginostic Pte. Ltd. He established a world-class joint platform for the immunodiagnosis at the tissue level. The platform allows the researchers, clinicians, and pharma to profile the patient immune signature for diagnosis, prognosis, and drug response study.

Dr. Motoki Takagi received PhD from Graduate School of Agriculture and Life Sciences, the University of Tokyo in 2001. Then he continued his research as a postdoctoral fellow at Institute of Molecular and Cellular Biosciences, the University of Tokyo. He was engaged in the research of nucleic acid drugs at Genencare Research Institute, Co. Ltd. since 2002. Since 2006, he conducted drug discovery research at Biological Systems Control Team, Biomedicinal Information Research Center, Japan Biological Informatics Consortium. Since 2012, he has been researching chemical biology as an associate professor at Fukushima Medical University and became a professor in 2014.

Dr. Ningbo Wu is an Associate Professor at Shanghai Institute of immunology, Shanghai Jiaotong University School of Medicine. His research interests mainly focus on the function of intestinal stromal cells in intestinal homeostasis and related work was published in Nature and Science CHINA Life Sciences, et al.

Nuno Costa-Borges is devoted to offering quality control (QC) tests, training, and consulting services to the IVF community worldwide. With over 18 years’ experience, Nuno completed a PhD focused on improving animal cloning efficiency before joining IVI Barcelona as a clinical embryologist. Now, as cofounder and scientific director of Embryotools, Nuno is committed to developing new IVF techniques, which have led to the world’s first babies via maternal spindle transfer for infertility and to the development of the first robotic system for intracytoplasmic sperm injection successfully tested clinically.

Akira studied veterinary medicine at Tokyo University of Agriculture and Technology, Japan and graduated in 2007. Shortly after, he joined Olympus as application specialist responsible for in vivo imaging systems, high-content analysis systems, and laser confocal systems to support customers in Japan. In 2013, he took over sales promotion for all Olympus life science products. From 2018, he moved to Singapore and joined to support the marketing and application support for the APAC market.

Bob McLean has over 30 years’ experience as a microbiologist, during which time he and his lab have done a number of studies on surface-adherent microorganisms (biofilms). In 1998, he and his colleagues had an experiment on the space shuttle with John Glenn, in which they were one of the first research groups to show that biofilms could form in microgravity. Since that discovery, there have been a number of biofilm issues, notably instances of fouling in the water recovery system in the International Space Station and other spacecraft. In 2015, Bob, along with collaborators at Arizona State and the Johnson Space Center, received a NASA grant to study biofilm formation during spaceflight. Confocal and other types of microscopy have been instrumental in these investigations.

Jesse completed his Ph.D. at the University of British Columbia (UBC) in cell biology and genomics. He then continued his training at the University of California, San Diego. After, he switched his focus to developing machine learning approaches for assessing the physiological impacts of genetic variants associated with hereditary cancer at UBC. During this time, he started to develop deep learning approaches to automated phenotypic profiling based on high-content imaging data.

James Lopez received his Ph.D. in biomedical sciences from the University of Chicago in 2010. With nearly a decade of experience in calcium imaging, FRET, live cell imaging, and intravital imaging, James joined Olympus as a confocal and multiphoton sales representative. He later transitioned to the Olympus Life Science Applications Group, supporting confocal and multiphoton systems. Now he manages the Life Science Applications Group in the US, Canada, and Latin America markets.

Yosuke Yoneyama obtained his Ph.D. from The University of Tokyo in Japan, where he continued his post-doctoral work on insulin/insulin-like growth factor signaling with a focus on spatiotemporal control of the intracellular signaling system in the laboratory of Dr. Shin-Ichiro Takahashi. He then joined the laboratory of Dr. Takanori Takebe at Tokyo Medical and Dental University in Japan as an assistant professor. He now focuses on human organoids, in particular liver organoids, that are derived from stem cells, including induced pluripotent stem cells (iPSCs), to reconstitute multiple lineages of liver cells both for human development and modeling diseases such as non-alcoholic steatohepatitis.

Professor Ewa M. Goldys is Deputy Director of the Australian Research Council Centre of Excellence in Nanoscale Biophotonics (cnbp.org.au) and Professor at the Graduate School of Biomedical Engineering, the University of New South Wales, Sydney, Australia.  She is Fellow of SPIE, OSA, the Australian Academy of Technological Science and Engineering (ATSE), and winner of the 2016 Australian Museum Eureka Prize for ‘Innovative Use of Technology.’ She has ongoing involvement with SPIE BIOS, the world's largest international biomedical optics meeting and SPIE's Photonics West where she serves as Track Chair in Nanobiophotonics.

Her research spans the areas of biomedical science, bioimaging, biosensing, and materials science. She developed novel approaches to biochemical and medical sensing and deployable medical diagnostics. Current projects focus on cancer nanotechnology and non-invasive high-content imaging of colors and patterns in cells and tissues.

Dr. Laura Vittadello is working as a post-doc in the physics department of the Osnabrück University in the ultrafast physics research group. Her research focus is on the fundamental study and application of a new type of marker, harmonic nanoparticles, that are specially designed for biological applications that involve nonlinear microscopy.

After receiving his M.Sc. in Biological Sciences from the University of Pisa in Oct 2003 and his Diploma in Biological Sciences in the same year (both with honors) from SNS, Francesco Cardarelli worked at the NEST Laboratory of SNS as a Ph.D. student in Molecular Biophysics under the supervision of Prof. Fabio Beltram. He started his interdisciplinary research at the crossroads between cell biology and physics, using advanced fluorescence microscopy methods to study the intracellular transport properties of virus-derived peptide sequences. After graduating, he became a Post-Doctoral Fellow at the Laboratory for Fluorescence Dynamics, University of California at Irvine, under the supervision of Prof. Enrico Gratton, where he coordinated the research activity for the development of new spatial variants of fluorescence correlation spectroscopy to detect barriers to molecular diffusion/flow in live cells. In Dec 2010 he was hired by the CNI@NEST (IIT) as a Post-Doctoral Fellow. Back in Italy, he started working to develop new fluorescence-based imaging and analysis methods to study single molecules in complex biological systems with high spatiotemporal resolution. This research was boosted by a number of funded grants (and established collaborations) and by an independent scientific position, first at CNR as a Researcher, then at SNS as Professor in Applied Physics.

The focus of his research is on the development of new optical microscopy techniques to increase the amount of quantitative information that can be extracted from investigations on living matter. For instance, in recent years, he and his team introduced a number of new spatiotemporal fluctuation-analysis tools (iMSD, iRICS, nD-pCF, diffusion tensor analysis, etc.) to extract structural and dynamic properties of biological objects, from molecules to entire sub-cellular structures, in their complex natural environment. Such a toolbox is becoming a new paradigm for biophysical investigations at the nanoscale, as featured in the “New and Notable” section of Biophysical Journal (2016 Aug 23; 111(4): 677–678). In 2014, together with his Team, they demonstrated the occurrence of short-range protein Brownian motion in the cell cytoplasm, being among the first to challenge the current view of the structural organization of the crowded intracellular environment. Finally, by combining this toolbox with feedback-based orbital tracking, they demonstrated that even the nanoscopic and dynamic environment of intracellular organelles can be quantitatively probed.

Dr. Roy completed a double-major in Biochemistry and Microbiology followed by the completion of a Doctor of Philosophy in 2002 in the field of Molecular Biology/Cell Biology at the University of Queensland Australia. She travelled abroad to undertake a post-doctoral position at Washington University in St Louis, USA. She then returned to Australia to continue her post-doctoral studies.

With her extensive microscopy experience, she was appointed as the University of Queensland Diamantina Institute Microscopy Facility Manager in 2009 and later as manager of microscopy services at the Translational Research Institute in Brisbane until 2019.

She is now Business Development Manager at Olympus Australia, where her experience and knowledge is used to support customers both in Australia and New Zealand.

Seungil Kim, Ph.D., is a Staff Scientist and Microscopy Team Manager at the Lawrence J. Ellison Institute for Transformative Medicine at USC. Dr. Kim completed his B.S. and M.S. degrees in South Korea. He then moved to Washington University and received a doctoral degree in Developmental Biology. He carried out his postdoctoral research in the department of Cell and Tissue Biology at UCSF. Seungil has over 10 years of experience working with various in vitro/in vivo models and advanced cellular imaging techniques. His current research focus is to understand the contributions of the tumor microenvironment to drug response, using patient-derived 3D organoids as a model system. Moreover, he is developing high-throughput automated imaging methods to screen novel drug compounds in colorectal cancer.

Alfonso has a decade of experience working in a shared resource lab (SRL) with a vast knowledge in histology, fluorescent microscopy, and image analysis. His work has been focused in maximizing the capabilities of the equipment available and in creating technical protocols and training modules for the scientific community. Currently, Alfonso oversees the Histology and Bioimaging Facility as part of the Hugh Green Cytometry Centre (HGCC) at the Malaghan Institute of Medical Research in Wellington, New Zealand.

Tong Wu joined Olympus in 2012 after completing her Ph.D. in China (State Key Laboratory of Fine Chemicals, DLUT). Now, Tong is a business development manager, supporting high-end microscopes in Olympus Australia. With a research background in fluorescent dyes for bio-imaging and bio-labelling, Tong Wu is enthusiastic to engage with customers’ research applications.

Prof. Portugues is a neurobiologist studying sensorimotor control. His research group uses behavior, modeling, optogenetics, in vivo electrophysiology, and whole brain functional calcium imaging to dissect learning, memory, and action selection in the larval zebrafish.

Prof. Portugues studied mathematics and did his Ph.D. in theoretical physics at Trinity College in the University of Cambridge. After a short postdoctoral fellowship in physics at Centro de Estudios Cientificos in Valdivia, Chile, he joined Professor Florian Engert’s laboratory at Harvard University and switched research interests to neuroscience. In 2014 he was appointed Max Planck Research Group Leader at the Max Planck Institute of Neurobiology in Martinsried. Since 2020 Prof. Portugues is an assistant professor at the TUM.

Atsuya Toda is an assistant manager for Global Life Science Marketing at Evident. He has more than fifteen years’ experience in life science microscopy sales, sales planning, and marketing in Japan. In 2021, he moved to the Global Life Science Marketing team where he is the marketing representative for the APEXVIEW APX100 all-in-one microscope. He holds a Bachelor of Economics degree from Doshisha University, Japan.

Laura Lleras Forero is the product marketing manager for cell culture products at Evident. She completed her PhD at King’s College London and undertook postdocs in Utrecht, Berlin, and Münster. She has been with Evident since 2021, supporting cell culture microscopy solutions, the SLIDEVIEW™ VS200 research slide scanner, and the APEXVIEW™ APX100 all-in-one microscope for Europe, the Middle East, and Africa (EMEA).

Ines Hartmann is an application specialist for cell handling at the Eppendorf headquarters in Hamburg, Germany. She joined the company in 2008 and has worked on several topics in cell handling, liquid handling, and consumables. She obtained her diploma degree in biology at the Humboldt University of Berlin, Germany and has expertise in various laboratory techniques.

Featured Speaker Amin El-Heliebi (Professor) Professor Amin El-Heliebi was educated in Graz, Stockholm and Buenos Aires and was appointed Research Professor 2021 at the Medical University of Graz, Austria. His research focus lies in molecular biomarkers, cancer research, liquid biopsy, tumor biology, and spatial transcriptomics. His overarching research question deals with understanding tumor dissemination. His research group investigates liquid biopsies, such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). Their overall aim is to track and trace liquid biopsies back to the originating tumor mass and identify the mechanisms involved in spreading of metastatic disease.